• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC INC. INTERSTIM NEUROSTIMULATOR MODEL 3057; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC INC. INTERSTIM NEUROSTIMULATOR MODEL 3057; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 3057
Device Problems Break (1069); Entrapment of Device (1212); Defective Component (2292)
Patient Problems Failure of Implant (1924); Undesired Nerve Stimulation (1980); Brain Injury (2219); Nervous System Injury (2689); Device Embedded In Tissue or Plaque (3165)
Event Date 03/14/2015
Event Type  Injury  
Event Description
Re: medtronic interstim neurostimulator device model 3057.I have been a medtronic interstim neurostimulator implant patient since 2009.My first interstim was the 3057 implanted in 2009 by dr (b)(6) in (b)(6) and the device performed very well.When the battery came to the end of its life, a replacement 3057 battery pack was inserted in 2014 by dr (b)(6) of (b)(6).Soon after that surgery i developed what seemed like electric shocks or short circuits in the vaginal/rectal area and an urgent replacement 3057 surgery had to be carried out in (b)(6) 2015 by dr (b)(6) of (b)(6) (as dr (b)(6) was 'on vacation' and my situation was urgent).Post-surgery, dr (b)(6) informed me that a broken lead was inside me as he was unable to remove it.This was the first i had heard of any issue with a lead having broken or have any notice that a lead could actually break off! nobody at medtronic nor my surgeons had even mooted that this could be a possibility.The medtronic rep who was present during this particular procedure never told me afterwards ¿ not a word.Isn't medtronic supposed to alert its patients and the fda of any adverse situation involving devices that break inside the patient? moving to (b)(6) in 2016 i came under the care of dr (b)(6) who has been in charge of my medtronic neurostimulator care and surgeries since then.After my latest device came to the end of its battery life in (b)(6) 2021, dr (b)(6) implanted the latest model (the rechargeable interstim 97810) which is mri compliant (unfortunately this device is also defective and i will be making a report about this separately to you).After this last surgery ((b)(6) 2021) dr (b)(6) said that he could "see the tip" of the broken lead but it was too deep to be removed by him safely.Due to a spinal and brain injury in 2021, i have been in need of mris, but due to the defective neurostimulator medtronic inserted and which broke off and is still inside me - i am unable to have mris.This has been my first opportunity to report this particular device as i didn't know prior to today that i would be able to report the adverse effect.Medtronic never alerted me to the fact that the device had the potential to break inside the patient, never acknowledged that i had an issue with the device and, indeed, never communicated with me at any time about the 3057 broken lead.Due to the defective product, i have been left without the option to have medical procedures that are available to others.I also underwent replacement surgery, but the abandoned lead could not be recovered and is still inside me.Fda safety report id #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM NEUROSTIMULATOR MODEL 3057
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC INC.
MDR Report Key15470342
MDR Text Key300649805
Report NumberMW5112219
Device Sequence Number1
Product Code EZW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 09/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number3057
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/22/2022
Patient Sequence Number1
Treatment
VIIBRYD 40 MG, 20 MG BELSOMRA, QULIPTA.
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age45 YR
Patient SexFemale
Patient Weight68 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-